Skip to main content

Table 2 Outcome scores and estimates of effects of all outcome measures for the control group and experimental group.

From: Feasibility and results of a randomised pilot-study of pre-discharge occupational therapy home visits

  

OUTCOME SCORE

ANCOVA-ADJUSTED ESTIMATES OF EFFECTS*

p-value

Outcome Measure

 

Control

Experimental

  

Functional Independence Measure: total score (sd), 0–126

2 weeks

115.2 (± 6.3)

117.7 (± 3.3)

2.5 (-6.7 to 11.9)

.525

 

1 month

116.5 (± 7.4)

117.7 (± 3.9)

1.3 (-10.6 to 13.27)

.788

 

2 months

112.2 (± 10.0)

120.0 (± 2.1)

8.72 (-3.4 to 20.9)

.125

 

3 months

118.0 (± 4.0)

115.7 (± 6.8)

-0.1 (-13.9 to 13.8)

.982

Reintegration to Normal Living Index: total score (sd), 0–100

2 weeks

59.2 (± 20.3)

63.0 (± 9.6)

4.1 (-27.5 to 35.6)

.754

 

1 month

56.7 (± 23.7)

56.2 (± 15.8)

0.8 (-34.8 to 36.5)

.953

 

2 months

53.2 (± 38.6)

83.0 (± 9.5)

30.5 (-39.7 to 100.8)

.294

 

3 months

83.6 (± 9.8)

82.0 (± 8.2)

-1.7 (-22.8 to 19.4)

.835

Nottingham Extended Activities of Daily Living scale: total score (sd), 0–66

2 weeks

37.2 (± 10.9)

45.7 (± 5.9)

16.1 (4.9 to 27.1)

.012

 

1 month

33.7 (± 20.1)

46.7 (± 3.4)

17.0 (-12.88 to 46.95)

.203

 

2 months

36.0 (± 13.9)

51.7 (± 3.1)

23.0 (12.2 to 33.8)

.003

 

3 months

43.3 (± 7.1)

56.7 (± 2.2)

17.6 (-3.2 to 38.5)

.079

Tinnetti Performance Oriented Mobility Scale: total score (sd) 0–28

2 weeks

20.3 (± 2.9)

20.0 (± 1.4)

0.5 (-3.0 to 4.2)

.639

 

1 month

22.0 (± 1.4)

24.0 (± 6.9)

2.2 (-8.9 to 13.2)

.639

 

2 months

17.0 (± 11.5)

22.7 (± 2.7)

2.7 (-13.9 to 19.3)

.694

 

3 months

23.0 (± 1.7)

23.5 (± 1.7)

0.5 (-3.8 to 4.8)

.779

Falls Efficacy Scale- International: total score (sd), 0–64

2 weeks

33.6 (± 7.1)

30.2 (± 8.9)

-2.3 (-18.1 to 13.5)

.735

 

1 month

31.5 (± 8.0)

28.5 (± 7.3)

-2.5 (-19.8 to 14.7)

.722

 

2 months

36.2 (± 9.5)

23.2 (± 4.2)

-14.8 (-30.7 to 1.17)

.063

 

3 months

30.0 (± 3.0)

22.2 (± 4.5)

-3.2 (-10.5 to 4.1)

.287

EQ-5D VAS: total score (sd), 0–100

2 weeks

35.2 (± 30.8)

69.2 (± 11.3)

21.4 (-21.1 to 64.0)

.252

 

1 month

62.25 (± 18.0)

79.3 (± 10.1)

8.6 (-21.4 to 38.8)

.470

 

2 months

48.3(± 32.4)

87.0 (± 9.2)

31.7 (-23.4 to 86.9)

.185

 

3 months

54.0 (± 25.0)

85.0 (± 8.5)

23.3 (-17.4 to 64.1)

.187

  1. * Between-group differences adjusted for the baseline value of the outcome Larger scores reflect decreased risk except for the FES-I